{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:25:36Z","timestamp":1780413936520,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013465","name":"Association fran\u00e7aise contre les myopathies","doi-asserted-by":"publisher","award":["16123"],"award-info":[{"award-number":["16123"]}],"id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005362","name":"University of Bari","doi-asserted-by":"publisher","award":["2017\u20132018"],"award-info":[{"award-number":["2017\u20132018"]}],"id":[{"id":"10.13039\/501100005362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016980","name":"Bahria University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.expneurol.2021.113758","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T11:19:32Z","timestamp":1620818372000},"page":"113758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders"],"prefix":"10.1016","volume":"342","author":[{"given":"Concetta","family":"Altamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Fonzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Liantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Imbrici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Carrat\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabata","family":"Pierno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Desaphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2021.113758_bb0005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1085\/jgp.116.3.433","article-title":"Fast and slow gating relaxations in the muscle chloride channel CLC-1","volume":"116","author":"Accardi","year":"2000","journal-title":"J. Gen. Physiol."},{"issue":"9","key":"10.1016\/j.expneurol.2021.113758_bb0010","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/humu.23581","article-title":"The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel","volume":"39","author":"Altamura","year":"2018","journal-title":"Hum. Mutat."},{"issue":"10","key":"10.1016\/j.expneurol.2021.113758_bb0015","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1111\/bph.14192","article-title":"Mapping ligand binding pockets in chloride ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid","volume":"175","author":"Altamura","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.expneurol.2021.113758_bb0020","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00424-020-02376-3","article-title":"Skeletal muscle ClC-1 chloride channels in health and diseases","volume":"472","author":"Altamura","year":"2020","journal-title":"Pflugers Arch."},{"issue":"7","key":"10.1016\/j.expneurol.2021.113758_bb0025","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.nmd.2020.04.006","article-title":"Non-dystrophic myotonia Chilean cohort with predominance of the SCN4A Gly1306Glu variant","volume":"30","author":"Avila-Smirnow","year":"2020","journal-title":"Neuromuscul. Disord."},{"issue":"7","key":"10.1016\/j.expneurol.2021.113758_bb0030","doi-asserted-by":"crossref","first-page":"C1019","DOI":"10.1152\/ajpcell.00279.2011","article-title":"Lactic acid restores skeletal muscle force in an in vitro fatigue model: are voltage-gated chloride channels involved? Am","volume":"302","author":"Bandschapp","year":"2012","journal-title":"J. Physiol. Cell Physiol."},{"issue":"37","key":"10.1016\/j.expneurol.2021.113758_bb0035","doi-asserted-by":"crossref","first-page":"32452","DOI":"10.1074\/jbc.M502890200","article-title":"Cytoplasmic ATP-sensing domains regulate gating of skeletal muscle ClC-1 chloride channels","volume":"280","author":"Bennetts","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.expneurol.2021.113758_bb0040","doi-asserted-by":"crossref","first-page":"32780","DOI":"10.1074\/jbc.M703259200","article-title":"Inhibition of skeletal muscle ClC-1 chloride channels by low intracellular pH and ATP","volume":"282","author":"Bennetts","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"31","key":"10.1016\/j.expneurol.2021.113758_bb0045","doi-asserted-by":"crossref","first-page":"25808","DOI":"10.1074\/jbc.M111.327551","article-title":"Intracellular \u03b2-nicotinamide adenine dinucleotide inhibits the skeletal muscle ClC-1 chloride channel","volume":"287","author":"Bennetts","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.expneurol.2021.113758_bb0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1017\/S0317167100026305","article-title":"Treatment of paramyotonia congenita with acetazolamide","volume":"14","author":"Benstead","year":"1987","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2021.113758_bb0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.taap.2016.06.032","article-title":"Statin-induced myotoxicity is exacerbated by aging: a biophysical and molecular biology study in rats treated with atorvastatin","volume":"306","author":"Camerino","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.expneurol.2021.113758_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1085\/jgp.118.1.23","article-title":"Different fast-gate regulation by external Cl(\u2212) and H(+) of the muscle-type ClC chloride channels","volume":"118","author":"Chen","year":"2001","journal-title":"J. Gen. Physiol."},{"issue":"Pt 23","key":"10.1016\/j.expneurol.2021.113758_bb0065","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1113\/jphysiol.2010.196568","article-title":"Lactate per se improves the excitability of depolarized rat skeletal muscle by reducing the Cl- conductance","volume":"588","author":"de Paoli","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2021.113758_bb0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nmd.2013.02.007","article-title":"Long-term effectiveness of acetazolamide on permanent weakness in hyperkalemic periodic paralysis","volume":"23","author":"Dejthevaporn","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2021.113758_bb0075","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.expneurol.2013.07.018","article-title":"Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenital presenting with different clinical phenotypes","volume":"248","author":"Desaphy","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2021.113758_bb0080","doi-asserted-by":"crossref","first-page":"113287","DOI":"10.1016\/j.expneurol.2020.113287","article-title":"Safinamide\u2019s potential in treating nondystrophic myotonias: inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo","volume":"328","author":"Desaphy","year":"2020","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2021.113758_bb0085","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1152\/japplphysiol.00256.2018","article-title":"Effect of acetazolamide and methazolamide on diaphragm and dorsiflexor fatigue: a randomized controlled trial","volume":"125","author":"Dominelli","year":"2018","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"2","key":"10.1016\/j.expneurol.2021.113758_bb0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ana.25780","article-title":"TRPV4 antagonism prevents mechanically induced myotonia","volume":"88","author":"Dupont","year":"2020","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2021.113758_bb0095","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mus.20585","article-title":"Acetazolamide acts directly on the human skeletal muscle chloride channel","volume":"34","author":"Eguchi","year":"2006","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.expneurol.2021.113758_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nmd.2006.01.015","article-title":"A new case of autosomal dominant myotonia associated with the V1589M missense mutation in the muscle sodium channel gene and its phenotypic classification","volume":"16","author":"Ferriby","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2021.113758_bb0105","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1096\/fj.02-1012fje","article-title":"Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle","volume":"17","author":"Fraysse","year":"2003","journal-title":"FASEB J."},{"issue":"20","key":"10.1016\/j.expneurol.2021.113758_bb0110","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1113\/JP274638","article-title":"Elevated resting H+ current in the R1239H type 1 hypokalaemic periodic paralysis mutated Ca2+ channel","volume":"595","author":"Fuster","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2021.113758_bb0115","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1152\/japplphysiol.00746.2001","article-title":"Acetazolamide reduces exercise capacity and increases leg fatigue under hypoxic conditions","volume":"94","author":"Garske","year":"2003","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.expneurol.2021.113758_bb0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/ng0493-305","article-title":"Molecular basis of Thomsen\u2019s disease (autosomal dominant myotonia congenital)","volume":"3","author":"George","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2021.113758_bb0125","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.resp.2012.08.023","article-title":"Effect of acetazolamide on respiratory muscle fatigue in humans","volume":"185","author":"Gonzales","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"1","key":"10.1016\/j.expneurol.2021.113758_bb0130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0003-2697(86)90174-0","article-title":"Characteristics of fluoroprobes for measuring intracellular pH","volume":"156","author":"Graber","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.expneurol.2021.113758_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/0003-4819-73-1-39","article-title":"Acetazolamide treatment of hypokalemic periodic paralysis: prevention of attacks and improvement of persistent weakness","volume":"73","author":"Griggs","year":"1970","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.expneurol.2021.113758_bb0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ana.410030614","article-title":"Effects of acetazolamide on myotonia","volume":"3","author":"Griggs","year":"1978","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2021.113758_bb0145","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1379744","article-title":"The skeletal muscle chloride channel in dominant and recessive human myotonia","volume":"257","author":"Koch","year":"1992","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.expneurol.2021.113758_bb0150","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1113\/expphysiol.2005.031435","article-title":"N-Benzyl-p-toluene sulphonamide allows the recording of trains of intracellular action potentials from nerve-stimulated intact fast-twitch skeletal muscle of the rat","volume":"90","author":"MacDonald","year":"2005","journal-title":"Exp. Physiol."},{"issue":"4","key":"10.1016\/j.expneurol.2021.113758_bb0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pediatrneurol.2014.05.027","article-title":"Clinical experience with long-term acetazolamide treatment in children with nondystrophic myotonias: a three-case report","volume":"51","author":"Markhorst","year":"2014","journal-title":"Pediatr. Neurol."},{"issue":"22","key":"10.1016\/j.expneurol.2021.113758_bb0160","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.0b013e31823a0cb6","article-title":"Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype","volume":"77","author":"Matthews","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.expneurol.2021.113758_bb0165","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/mus.24534","article-title":"Becker myotonia-a recently identified mutation in Iberian descendants with apparent acetazolamide-responsive phenotype","volume":"51","author":"Moreira","year":"2015","journal-title":"Muscle Nerve"},{"issue":"5687","key":"10.1016\/j.expneurol.2021.113758_bb0170","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1126\/science.1101141","article-title":"Intracellular acidosis enhances the excitability of working muscle","volume":"305","author":"Pedersen","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.expneurol.2021.113758_bb0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1085\/jgp.200409173","article-title":"Increased excitability of acidified skeletal muscle: role of chloride conductance","volume":"125","author":"Pedersen","year":"2005","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.expneurol.2021.113758_bb0180","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJM196803142781102","article-title":"Acetazolamide prophylaxis in hypokalemic periodic paralysis","volume":"278","author":"Resnick","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2021.113758_bb0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1113\/jphysiol.1996.sp021778","article-title":"Concentration and pH dependence of skeletal muscle chloride channel ClC-1","volume":"497","author":"Rychkov","year":"1996","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2021.113758_bb0190","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1085\/jgp.111.5.653","article-title":"Permeation and block of the skeletal muscle chloride channel, ClC-1, by foreign anions","volume":"111","author":"Rychkov","year":"1998","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.expneurol.2021.113758_bb0195","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1469-7793.2001.0379k.x","article-title":"Interaction of hydrophobic anions with the rat skeletal muscle chloride channel ClC-1: effects on permeation and gating","volume":"530","author":"Rychkov","year":"2001","journal-title":"J. Physiol."},{"issue":"15","key":"10.1016\/j.expneurol.2021.113758_bb0200","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0000000000002416","article-title":"Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis","volume":"86","author":"Sansone","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.expneurol.2021.113758_bb0205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1085\/jgp.113.3.457","article-title":"The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia","volume":"113","author":"Saviane","year":"1999","journal-title":"J. Gen. Physiol."},{"issue":"4","key":"10.1016\/j.expneurol.2021.113758_bb0210","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mus.26009","article-title":"Review of the diagnosis and treatment of periodic paralysis","volume":"57","author":"Statland","year":"2018","journal-title":"Muscle Nerve"},{"issue":"6351","key":"10.1016\/j.expneurol.2021.113758_bb0215","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/354301a0","article-title":"Primary structure and functional expression of a developmentally regulated skeletal muscle chloride channel","volume":"354","author":"Steinmeyer","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2021.113758_bb0220","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H","article-title":"Randomized trials of dichlorphenamide in the periodic paralyses: working group on periodic paralysis","volume":"47","author":"Tawil","year":"2000","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2021.113758_bb0225","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/1531-8249(200009)48:3<304::AID-ANA4>3.0.CO;2-A","article-title":"Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis","volume":"48","author":"Tricarico","year":"2000","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2021.113758_bb0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nmd.2005.10.005","article-title":"Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+\u2212activated-K+ channels","volume":"16","author":"Tricarico","year":"2006","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.expneurol.2021.113758_bb0235","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.37.3.488","article-title":"Acetazolamide-responsive myotonia congenita","volume":"37","author":"Trudell","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2021.113758_bb0240","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/archneur.1975.00490480051006","article-title":"Acetazolamide treatment of hypokalemic periodic paralysis: probable mechanism of action","volume":"32","author":"Vroom","year":"1975","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2021.113758_bb0245","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1085\/jgp.200810023","article-title":"ATP inhibition of CLC-1 is controlled by oxidation and reduction","volume":"132","author":"Zhang","year":"2008","journal-title":"J. Gen. Physiol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488621001643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488621001643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:06:10Z","timestamp":1758002770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488621001643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":49,"alternative-id":["S0014488621001643"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2021.113758","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2021.113758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113758"}}